Antibacterial agent for treating infectious diseases of bacterial origin
View Patent ↗The invention relates to medicine, namely to the antimicrobial agent for the treatment of infectious bacterial diseases including hospital infections and drug-resistant TB which represents the ion nanostructured complex (INSC) synthesized from carbohydrates proteins and/or polypeptides (albumins, interleukins, interferons, signaling proteins, etc), which are to enhance the antimicrobial activity in vivo, by activating immune cells that contain at least one terminal amino acid such as Phe, Ala, Val, Ala, Leu, Ile, and others with electron-donor functional groups, iodine and halides of the alkali and alkaline earth elements in the fourth stage at a certain ionic strength; an antibacterial agent increases: the susceptibility of bacteria, including antibiotic-resistant, to antibiotics; activity of monocytes and macrophages; efficiency of antibiotic treatment of hospital infections and drug-resistant TB; it also has antiviral activity, stimulates hematopoietic function of bone marrow; has an antitumor effect and radioprotective properties; in acceptable concentrations of components can be used as non-pharmaceutical agent (BAFS or parapharmaceutical); is presented in the pharmacological form suitable for parenteral, oral, external, or other application. INSC has the formula [{(Ln (MeI3)+) y [Me (Lm) I]+x} (Cl—) y+x+k] with M=30-300 kDa.
1. A method for producing an antimicrobial ionic nanostructured complex, the method comprising:
(a) combining carbohydrate selected from amylopectin, dextran, or dextrin with a salt mixture comprising an alkali metal salt selected from sodium chloride and lithium chloride, and an alkaline earth metal salt selected from magnesium chloride and calcium chloride in an aqueous medium to form an intermediate composition A;
(b) combining albumin with a salt mixture comprising an alkali metal salt selected from sodium chloride and lithium chloride, and an alkaline earth metal salt selected from magnesium chloride and calcium chloride to form an intermediate composition B;
(c) combining the intermediate composition A with the intermediate composition B to form an intermediate composition C,
(d) combining the intermediate composition C with potassium polyiodide, prepared by mixing iodine (I 2 ) and potassium iodide, to form the first ionic nanostructured complex (product D) in an aqueous medium,
wherein the first ionic nanostructured complex comprises an intercalated iodine, and wherein the aqueous medium has an ionic strength from about 3.0 to about 56.3 (moles per liter or moles per kilogram).
2. The method of claim 1 further comprising the steps of:
(e) combining the first ionic nanostructured complex (product D) with an intermediate composition B, which intermediate composition B is produced by combining albumin with a salt mixture comprising an alkali metal salt selected from sodium chloride and lithium chloride, and an alkaline earth metal salt selected from magnesium chloride and calcium chloride, and combine with an interleukin to form an intermediate mixture E; and
(f) combining intermediate mixture E with a potassium polyiodide, prepared by mixing iodine (I 2 ) and potassium iodide, to form a second ionic nanostructured complex (product F), wherein the second ionic nanostructured complex comprises an intercalated iodine.
3. The method according to claim 2 , wherein the interleukin is interleukin 2.
4. The method according to claim 1 , wherein the aqueous medium comprises dioxane.
5. The method according to claim 2 , wherein the aqueous medium comprises dioxane.
6. The method according to claim 1 , wherein the aqueous medium further comprises polyvinyl alcohol.
7. The method according to claim 2 , wherein the aqueous medium further comprises polyvinyl alcohol.
8. The method according to claim 3 , wherein the aqueous medium further comprises polyvinyl alcohol.